
NYR
Nyrada
Pharmaceuticals, Biotechnology & Life Sciences
Drug research and development
Short position
short percentage0.00%
reported shorts16
shares on issue258.682M
Nyrada (ASX:NYR) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.06% in September 2026. NYR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nyrada (NYR) company profile
Profile, insiders and operations
NYR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required